NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
10/15/2024
Back to search
Official data from USPTO
SPECTRIX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SPECTRIX THERAPEUTICS
ST13
US500000087031535Class
42
Filing
87031535
Registration
5424040
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
10/15/2024
Trademark type
Word
Nice classes
42
Filing date
05/10/2016
Registration date
03/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
09/10/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/21/2017
First use in commerce
09/21/2017
Drawing code
4
Owner type
16
Owner location
Northlake, TX, US
Examiner
CHOSID, ROBIN S
Current location
Historical data usage
Holders and representatives
Holders
Spectrix Therapeutics, LLC
Spectrix Therapeutics, LLC
Representatives
Daniel J. Chalker Chalker Flores, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of pharmaceutical preparations for others; Research and development of technology in the field of pharmaceutical preparations for others
Publications
History of USPTO decisions and trademark events.
36 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/10/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/10/2024
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
09/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/05/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/13/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/06/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/05/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/16/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/28/2017
IUAF
USE AMENDMENT FILED
12/13/2017
EISU
TEAS STATEMENT OF USE RECEIVED
12/13/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/13/2017
EX1G
SOU EXTENSION 1 GRANTED
06/09/2017
EXT1
SOU EXTENSION 1 FILED
06/09/2017
EEXT
SOU TEAS EXTENSION RECEIVED
06/09/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2016
PUBO
PUBLISHED FOR OPPOSITION
10/18/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/12/2016
ALIE
ASSIGNED TO LIE
09/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/19/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/19/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/19/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/19/2016
DOCK
ASSIGNED TO EXAMINER
08/19/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2016
NWAP
NEW APPLICATION ENTERED
05/13/2016
Continuous trademark protection
Get notified about every new filing that threatens SPECTRIX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.